<DOC>
	<DOCNO>NCT01459146</DOCNO>
	<brief_summary>The purpose study determine Artemisinin-based Combination Therapy , ACT , ( artemether-lumefantrine ) use intermittent preventive treatment ( IPT ) alone combination praziquantel , effect anemia , malaria , schistosomiasis school sustain attention concentration .</brief_summary>
	<brief_title>Artemisinin-based Combination Therapy-Intermittent Preventive Treatment ( ACT-IPT ) Trial Among Schoolchildren Kassena-Nankana , Ghana</brief_title>
	<detailed_description>Introduction : Malaria , schistosomiasis soil-transmitted helminth ( STH ) infection rife sub-Saharan Africa school child great risk morbidity . Although strategy use intermittent preventive treatment ( IPT ) malaria control proven beneficial among infant pregnant woman , yet implement school child large scale . Sulfadoxine-pyrimethamine ( SP ) use IPT limit widespread report resistance . Artemisinin-based combination therapy ( ACT ) proven efficacious IPT among school child study . Other study show artemisinin derivative exhibit anti-schistosomal activity . This could add effect use ACTs , IPT , prevent malaria relate morbidity school child sub-Saharan Africa . General Objective : To examine effect IPT ACTs anti-helminthes malaria helminthes infection health school attention among child 6 12 year old . Specific objectives 1 . To estimate prevalence malaria parasitemia , schistosomiasis anemia among primary schoolchildren . 2 . To determine impact 3 dos IPT ( artemether-lumefantrine ) de-worming ( albendazole and/or praziquantel ) hemoglobin school ( classroom ) attention recall . 3 . To determine effect IPT ( artemether-lumefantrine ) de-worming ( albendazole /or praziquantel ) prevalence intensity schistosomes infection among schoolchildren . 4 . To determine safety tolerability IPT artemether-lumefantrine combine albendazole and/or praziquantel among school child . Materials method : An open-labeled randomized trial , include 3 arm , carry 6 primary school Kassena-Nankana Districts , Ghana , malaria schistosome infection ( S. hematobium S. mansoni ) endemic . After informed consent assent obtain , 345 ( 115 arm ) class three school child investigate malaria parasitemia , anemia , schistosome soil-transmitted helminth infection , classroom attention recall baseline pre-intervention survey . Mass treatment carry 6 randomize school ACT albendazole one study arm ; ACT , albendazole praziquantel second arm albendazole praziquantel give third school arm . ACT mass treatment use artemether-lumefantrine carried every school term ( 4 monthly ) one year praziquantel give albendazole twice year . After one academic year , 345 ( 115 arm ) select participant class three assess hemoglobin , malaria parasitemia , STH schistosome infection classroom attention recall . Safety tolerability combine IPT assess 28 day post treatment . Data analysis- Data analyze intention-to-treat per-protocol employ uni-variate multivariate logistic regression analysis .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Helminthiasis</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinine</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Parental inform consent assent schoolchildren No known history allergy study drug Aged 6 year lack parental informed consent assent schoolchildren Known allergy history allergy study drug Aged le 6 year</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>IPT</keyword>
	<keyword>malaria</keyword>
	<keyword>ACT</keyword>
	<keyword>schistosomiasis</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Anemia</keyword>
	<keyword>Sustained attention</keyword>
	<keyword>Recall</keyword>
	<keyword>Schoolchildren</keyword>
	<keyword>Kassena-Nankana</keyword>
</DOC>